Literature DB >> 16389670

Longitudinal analysis of censored medical cost data.

Onur Başer1, Joseph C Gardiner, Cathy J Bradley, Hüseyin Yüce, Charles Given.   

Abstract

This paper applies the inverse probability weighted (IPW) least-squares method to estimate the effects of treatment on total medical cost, subject to censoring, in a panel-data setting. IPW pooled ordinary-least squares (POLS) and IPW random effects (RE) models are used. Because total medical cost might not be independent of survival time under administrative censoring, unweighted POLS and RE cannot be used with censored data, to assess the effects of certain explanatory variables. Even under the violation of this independency, IPW estimation gives consistent asymptotic normal coefficients with easily computable standard errors. A traditional and robust form of the Hausman test can be used to compare weighted and unweighted least squares estimators. The methods are applied to a sample of 201 Medicare beneficiaries diagnosed with lung cancer between 1994 and 1997.

Entities:  

Mesh:

Year:  2006        PMID: 16389670     DOI: 10.1002/hec.1087

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  5 in total

1.  Semiparametric Estimation of Longitudinal Medical Cost Trajectory.

Authors:  Liang Li; Chih-Hsien Wu; Jing Ning; Xuelin Huang; Ya-Chen Tina Shih; Yu Shen
Journal:  J Am Stat Assoc       Date:  2018-06-18       Impact factor: 5.033

2.  Evaluating the Implementation of Digital and In-Person Diabetes Prevention Program in a Large, Integrated Health System: Natural Experiment Study Design.

Authors:  Stephanie L Fitzpatrick; Meghan Mayhew; Chris L Catlin; Alison Firemark; Inga Gruß; Denis B Nyongesa; Maureen O'Keeffe-Rosetti; Andreea M Rawlings; David H Smith; Ning Smith; Victor J Stevens; William M Vollmer; Stephen P Fortmann
Journal:  Perm J       Date:  2021-12-13

Review 3.  Considerations for observational research using large data sets in radiation oncology.

Authors:  Reshma Jagsi; Justin E Bekelman; Aileen Chen; Ronald C Chen; Karen Hoffman; Ya-Chen Tina Shih; Benjamin D Smith; James B Yu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-09-01       Impact factor: 7.038

4.  Improving diabetic patients' adherence to treatment and prevention of cardiovascular disease (Office Guidelines Applied to Practice-IMPACT Study)-a cluster randomized controlled effectiveness trial.

Authors:  Adesuwa Olomu; Karen Kelly-Blake; William Hart-Davidson; Joseph Gardiner; Zhehui Luo; Michele Heisler; Margaret Holmes-Rovner
Journal:  Trials       Date:  2022-08-15       Impact factor: 2.728

5.  Predicting costs of care in heart failure patients.

Authors:  David H Smith; Eric S Johnson; David K Blough; Micah L Thorp; Xiuhai Yang; Amanda F Petrik; Kathy A Crispell
Journal:  BMC Health Serv Res       Date:  2012-11-30       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.